Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Beckman Coulter Genomics

This article was originally published in The Gray Sheet

Executive Summary

Newly formed genomic services division of Beckman Coulter combines the firm's Agencourt Bioscience unit and Cogenics, which was acquired in April for $17 million. Cogenics offers a range of integrated services for DNA and RNA extraction, genotyping and full sequencing services. Agencourt's sequencing platforms include the Roche 454 Genome Sequencer FLX with Titanium, Applied Biosystems SOLiD and Illumina Genome Analyzer II. Beckman bought Agencourt for $100 million in 2005 (1"The Gray Sheet" May 2, 2005, In Brief)

Related Content

Beckman Coulter bags Agencourt Bioscience





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts